Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value.
作者信息
Sawaya George F
机构信息
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco.
Department of Epidemiology & Biostatistics, University of California, San Francisco.
出版信息
JAMA Intern Med. 2018 Oct 1;178(10):1293-1295. doi: 10.1001/jamainternmed.2018.4282.
Abstract
摘要
相似文献
1
Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value.宫颈癌筛查——从证据的价值迈向价值的证据
JAMA Intern Med. 2018 Oct 1;178(10):1293-1295. doi: 10.1001/jamainternmed.2018.4282.
2
Do it yourself cervical cancer test: A gateway to increase cervical cancer screening in Pakistan.
J Pak Med Assoc. 2023 Apr;73(4):955. doi: 10.47391/JPMA.7755.
3
The renewal of the National Cervical Screening Program.国家宫颈癌筛查计划的更新。
Med J Aust. 2016 Oct 17;205(8):357-358. doi: 10.5694/mja16.00820.
4
Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.研究指出人乳头瘤病毒（HPV）宫颈癌筛查的价值：该检测可能是巴氏试验可行的替代方法。
Cancer. 2014 Dec 1;120(23):3589-90. doi: 10.1002/cncr.29126.
5
Investigating older women with an abnormal cervical screening test: Is anxiety an issue?对宫颈筛查检测结果异常的老年女性进行调查：焦虑是一个问题吗？
BJOG. 2023 Jan;130(2):201. doi: 10.1111/1471-0528.17336. Epub 2022 Nov 10.
6
Current status and future trends in cervical cancer screening.宫颈癌筛查的现状与未来趋势
Womens Health (Lond). 2014 Mar;10(2):129-33. doi: 10.2217/whe.13.65. Epub 2013 Oct 22.
7
Evidence that supports policies to delay cervical screening until after age 25 years.支持将宫颈癌筛查推迟至25岁以后的政策的证据。
CMAJ. 2017 Mar 13;189(10):E380-E381. doi: 10.1503/cmaj.160636.
8
Cervical cancer screening from Pap smear to human papillomavirus DNA testing.宫颈癌筛查：从巴氏涂片到人类乳头瘤病毒DNA检测
Compr Ther. 2001 Fall;27(3):202-8. doi: 10.1007/s12019-001-0015-3.
9
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.人乳头瘤病毒DNA检测与巴氏涂片检查用于宫颈癌筛查的比较
N Engl J Med. 2008 Feb 7;358(6):642; author reply 643.
10
Cervical screening: primary human papillomavirus testing.宫颈癌筛查：人乳头瘤病毒初筛
BJOG. 2012 May;119(6):650-2. doi: 10.1111/j.1471-0528.2012.03318.x.
引用本文的文献
1
Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross-Sectional Study.接种疫苗前HPV状态对中国女性疫苗效力的影响：一项多中心横断面研究
Cancer Rep (Hoboken). 2025 Sep;8(9):e70294. doi: 10.1002/cnr2.70294.
2
A Bayesian Logistic Regression Approach to Investigating the Determinants Associated with Never Having Been Screened for Cervical Cancer Amongst Child-Bearing-Age Women in Jordan.一种贝叶斯逻辑回归方法，用于调查约旦育龄妇女中从未接受过宫颈癌筛查的相关决定因素。
Int J Environ Res Public Health. 2025 Jun 25;22(7):1000. doi: 10.3390/ijerph22071000.
3
Factors associated with awareness of and undergoing Pap smear tests among Jordanian women.约旦女性中与巴氏涂片检查知晓率及接受检查相关的因素。
Narra J. 2024 Dec;4(3):e1018. doi: 10.52225/narra.v4i3.1018. Epub 2024 Sep 25.
4
Effects of screening coverage and screening quality assurance on cervical cancer mortality: Implication for integrated framework to monitor global implementation of cervical cancer screening programmes.筛查覆盖率和筛查质量保证对宫颈癌死亡率的影响：对监测全球宫颈癌筛查规划实施情况综合框架的启示。
J Glob Health. 2024 Oct 25;14:04189. doi: 10.7189/jogh.14.04189.
5
Cervical cancer screening in Jordan; a review of the past and an outlook to the future - facts and figures.约旦的宫颈癌筛查：回顾过去与展望未来——事实与数据
Prz Menopauzalny. 2023 Mar;22(1):24-29. doi: 10.5114/pm.2023.126345. Epub 2023 Mar 31.
6
Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells.敲低丙酮酸激酶M2可增强宫颈癌细胞的放射敏感性。
Cancer Cell Int. 2019 May 14;19:129. doi: 10.1186/s12935-019-0845-7. eCollection 2019.
本文引用的文献
1
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.人乳头瘤病毒高危型检测用于宫颈癌筛查：美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Aug 21;320(7):687-705. doi: 10.1001/jama.2018.10400.
2
Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.初级保健中的宫颈癌筛查：美国预防服务工作组的决策分析。
JAMA. 2018 Aug 21;320(7):706-714. doi: 10.1001/jama.2017.19872.
3
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.HPV 焦点随机临床试验：48 个月时，用初级宫颈 HPV 检测与细胞学检测筛查对高级别宫颈上皮内瘤变的影响。
JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464.
4
QALYs in 2018-Advantages and Concerns.2018年的质量调整生命年——优势与担忧
JAMA. 2018 Jun 26;319(24):2473-2474. doi: 10.1001/jama.2018.6072.
5
Practice Bulletin No. 168 Summary: Cervical Cancer Screening and Prevention.第168号实践公告摘要：宫颈癌筛查与预防
Obstet Gynecol. 2016 Oct;128(4):923-925. doi: 10.1097/AOG.0000000000001699.
6
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.乳腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Feb 16;164(4):279-96. doi: 10.7326/M15-2886. Epub 2016 Jan 12.
7
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.用于宫颈癌筛查的主要高危型人乳头瘤病毒检测：临时临床指南。
Gynecol Oncol. 2015 Feb;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. Epub 2015 Jan 8.
8
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.美国心脏病学会/美国心脏协会关于临床实践指南和绩效指标中成本/价值方法的声明：美国心脏病学会/美国心脏协会绩效指标特别工作组和实践指南特别工作组的报告
Circulation. 2014 Jun 3;129(22):2329-45. doi: 10.1161/CIR.0000000000000042. Epub 2014 Mar 27.
9
The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance.宫颈筛查的意外后果：接受细胞学监测的女性的困扰
J Low Genit Tract Dis. 2014 Apr;18(2):142-50. doi: 10.1097/LGT.0b013e31829c97d8.
10
ACOG Practice Bulletin Number 131: Screening for cervical cancer.ACOG 实践通报第 131 号：宫颈癌筛查。
Obstet Gynecol. 2012 Nov;120(5):1222-38. doi: 10.1097/aog.0b013e318277c92a.
Zotero 插件